Thesis Advisor: Dr. Tinatin Brelidze Dr. Anton Wellstein
Education: Albert Ludwig University of Freiburg, B.Sc., Pharmaceutical Science, 2019
About: After graduating from the University of Freiburg in Germany in 2019, Joos participated in a post-baccalaureate research program at the National Institutes of Health. Here, he researched genetic risk factors associated with Parkinson’s Disease using genotyping technologies and bioinformatic approaches. In 2021, Joos started his Ph.D. at Georgetown University and joined Dr. Brelidze’s lab. Currently, he is researching the Ether-a-go-go 1 (EAG1) potassium channel, a voltage-dependent ion channel. While typically the expression of this channel is almost exclusively in the brain, the EAG1 channel has been shown to be overexpressed in many cancers. His current projects focus on how the EAG1 channel contributes to tumor progression, as well as characterizing several EAG1 channel modulators as potential cancer therapeutics.
Rotations:
Dr. Mark Burns
Dr. Anton Wellstein
Dr. Kathleen Maguire-Zeiss
Dr. Tinatin Brelidze
Academic Appointment(s)
- Primary
- PhD Student, Ph.D. Program in Pharmacology & Physiology
- PhD Student, Brelidze Lab